AIDS related opportunistic infections, going but not gone

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Archives of pharmacal research

• Publication date

  2002-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF02976619PMID 12135090
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Color Atlas and Synopsis of Clinical Dermatology

  2012cited by this paper
• Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS

  2001cited by this paper
• Pneumocystis Carinii Pneumonia *

  2001cited by this paper
• HIV-associated neurologic disease incidence changes:

  2001cited by this paper
• Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis

  2001cited by this paper
• Discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS.

  2000cited by this paper
• Diagnosis and Management of Increased Intracranial Pressure in Patients with AIDS and Cryptococcal Meningitis

  2000cited by this paper
• Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.

  2000cited by this paper
• Discontinuation of Mycobacterium avium Complex Prophylaxis in Patients with Antiretroviral TherapyInduced Increases in CD4+ Cell Count

  2000cited by this paper
• Diagnosis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients with polymerase chain reaction: a blinded comparison to standard methods.

  2000cited by this paper
• Stopping primary prophylaxis in HIV-1-infected patients at high risk of toxoplasma encephalitis. Swiss HIV Cohort Study.

  2000cited by this paper
• Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

  2000cited by this paper
• Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.

  2000cited by this paper
• Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups.

  2000cited by this paper
• Inflammatory Reactions in HIV-1Infected Persons after Initiation of Highly Active Antiretroviral Therapy

  2000cited by this paper
• Erosive mediastinal lymphadenitis associated with Mycobacterium avium infection in a pediatric acquired immunodeficiency syndrome patient.

  2000cited by this paper
• Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.

  2000cited by this paper
• Impact of highly active antiretroviral therapy on onset of Mycobacterium avium complex infection and cytomegalovirus disease in patients with AIDS

  2000cited by this paper
• Immune restoration disorders following HAART.

  1999cited by this paper
• Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients.

  1999cited by this paper
• Antiretroviral therapy. Immune restoration disease in HIV-infected patients on HAART.

  1999cited by this paper
• Antiretroviral therapy. Immune restoration disease in HIV-infected patients on HAART.

  1999cited by this paper
• AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

  1999cited by this paper
• Immune restoration disorders following HAART.

  1999cited by this paper
• Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

  1998cited by this paper
• Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.

  1998cited by this paper
• HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection

  1998cited by this paper
• Clusters of Pneumocystis carinii pneumonia: analysis of person-to-person transmission by genotyping.

  1998cited by this paper
• The yield of bone marrow biopsy and culture compared with blood culture in the evaluation of HIV-infected patients for mycobacterial and fungal infections.

  1998cited by this paper
• Clindamycin with primaquine vs. Trimethoprim-sulfamethoxazole therapy for mild and moderately severe Pneumocystis carinii pneumonia in patients with AIDS: a multicenter, double-blind, randomized trial (CTN 004). CTN-PCP Study Group.

  1998cited by this paper
• Clinical Investigations: InfectionCytomegalovirus Pneumonia in AIDS Patients: Value of Cytomegalovirus Culture From BAL Fluid and Correlation With Lung Disease

  1998cited by this paper
• Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients.

  1998cited by this paper
• Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

  1998cited by this paper
• Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trial Group.

  1997cited by this paper
• Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant

  1997cited by this paper
• Diagnosis of AIDS-related focal brain lesions

  1997cited by this paper
• Treatment of Mycobacterium avium in Human Immunodeficiency Virus-Infected Individuals

  1997cited by this paper
• Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.

  1997cited by this paper
• Parenteral Cidofovir for Cytomegalovirus Retinitis in Patients with AIDS: The HPMPC Peripheral Cytomegalovirus Retinitis Trial: A Randomized, Controlled Trial

  1997cited by this paper
• Intravenous Cidofovir for Peripheral Cytomegalovirus Retinitis in Patients with AIDS

  1997cited by this paper
• Mycobacteremia in patients with the acquired immunodeficiency syndrome.

  1997cited by this paper
• Causes of death of HIV-infected persons in Ottawa, Ontario, 1984-1995.

  1997influential reference
• Definition and diagnosis of cytomegalovirus colitis in patients infected by human immunodeficiency virus.

  1997cited by this paper
• Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group.

  1997cited by this paper
• Disseminated Mycobacterium avium complex infection: implications of recent clinical trials on prophylaxis and treatment.

  1997cited by this paper
• Atovaquone for salvage treatment and suppression of toxoplasmic encephalitis in patients with AIDS. Atovaquone/Toxoplasmic Encephalitis Study Group.

  1997cited by this paper
• High-resolution CT in the evaluation of clinically suspected Pneumocystis carinii pneumonia in AIDS patients with normal, equivocal, or nonspecific radiographic findings.

  1997cited by this paper
• DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNAs.

  1997cited by this paper
• Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group.

  1997cited by this paper
• Epidemiology of Mycobacterium avium Complex Disease

  1997cited by this paper
• Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group.

  1996cited by this paper
• Combination Foscarnet and Ganciclovir Therapy vs. Monotherapy for the Treatment of Relapsed Cytomegalovirus Retinitis in Patients with AIDS: The Cytomegalovirus Retreatment Trial

  1996cited by this paper
• Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.

  1996cited by this paper
• A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.

  1996cited by this paper
• Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.

  1996cited by this paper
• A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.

  1996cited by this paper
• Cytomegalovirus encephalitis.

  1996cited by this paper
• Comparison of Three Regimens for Treatment of Mild to Moderate Pneumocystis carinii Pneumonia in Patients with AIDS: A Double-Blind, Randomized Trial of Oral Trimethoprim-Sulfamethoxazole, Dapsone-Trimethoprim, and Clindamycin-Primaquine

  1996cited by this paper
• Ocular Infection and Immunity

  1996cited by this paper
• Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: a randomized comparison.

  1995cited by this paper
• Trends in Infectious Diseases and Cancers among Persons Dying of HIV Infection in the United States from 1987 to 1992

  1995cited by this paper
• Cytomegalovirus infections of the nervous system in patients with AIDS.

  1995influential reference
• Detection of herpesvirus DNA by nested polymerase chain reaction in cerebrospinal fluid of human immunodeficiency virus-infected persons with neurologic disease: a prospective evaluation.

  1995cited by this paper
• Decline in the incidence of cryptococcosis among HIV-infected patients.

  1995cited by this paper
• Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system.

  1995cited by this paper
• A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.

  1995cited by this paper
• Decline in the incidence of cryptococcosis among HIV-infected patients.

  1995cited by this paper
• [Mycobacterium avium complex].

  1995cited by this paper
• Oral Atovaquone compared with intravenous Pentamadine for Pneumocystis carinii pneumonia in patients with AIDS

  1995cited by this paper
• Oral Atovaquone Compared with Intravenous Pentamidine for Pneumocystis carinii Pneumonia in Patients with AIDS

  1994cited by this paper
• Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis.

  1994cited by this paper
• Clinical epidemiological study of 171 cases of cryptococcosis.

  1994cited by this paper
• The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients--a prospective study.

  1994cited by this paper
• Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team.

  1994cited by this paper
• Extracerebral toxoplasmosis in patients infected with HIV. A French National Survey.

  1994cited by this paper
• Environmental risk factors for acquisition of Mycobacterium avium complex in persons with human immunodeficiency virus infection.

  1994cited by this paper
• Mycobacterium-avium complex.

  1994cited by this paper
• Clarithromycin Therapy for Bacteremic Mycobacterium avium Complex Disease

  1994cited by this paper
• Pulmonary disease from nontuberculous mycobacteria in patients with human immunodeficiency virus.

  1994cited by this paper
• Disease due to the Mycobacterium avium complex in patients with AIDS: epidemiology and clinical syndrome.

  1994cited by this paper
• Sputum induction compared with bronchoalveolar lavage by Ballard catheter to diagnose Pneumocystis carinii pneumonia.

  1994cited by this paper
• Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: Experience in 23 patients

  1994cited by this paper
• Ganciclovir treatment of cytomegalovirus colitis in AIDS: a randomized, double-blind, placebo-controlled multicenter study.

  1993cited by this paper
• Gastrointestinal Cytomegalovirus Disease

  1993cited by this paper
• Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double-blind pilot trial.

  1993cited by this paper
• Evidence of previous infection with Mycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions.

  1993cited by this paper
• Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.

  1993cited by this paper
• Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team.

  1993cited by this paper
• Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.

  1993cited by this paper
• Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

  1992cited by this paper
• Low-Dose Trimethoprim-Sulfamethoxazole Prophylaxis for Toxoplasmic Encephalitis in Patients with AIDS

  1992cited by this paper
• Treatment of Mycobacterium avium Complex Bacteremia in AIDS with a Four-Drug Oral Regimen

  1992cited by this paper
• Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome.

  1992cited by this paper
• Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

  1992cited by this paper
• Treatment of Mycobacterium avium complex bacteremia in AIDS with a four-drug oral regimen. Rifampin, ethambutol, clofazimine, and ciprofloxacin. The California Collaborative Treatment Group.

  1992cited by this paper
• Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients.

  1992cited by this paper
• Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.

  1992cited by this paper
• Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends.

  1992cited by this paper
• Treatment of Toxoplasmic Encephalitis in Patients with AIDS

  1992cited by this paper
• A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.

  1991cited by this paper

• Epidemiología de la infección por el virus de inmunodeficiencia humana en pacientes hospitalizados en una institución de alta complejidad y enseñanza universitaria en Medellín, Colombia

  2016cites this paper
• Human Herpesviruses as Copathogens of HIV Infection, Their Role in HIV Transmission, and Disease Progression

  2016cites this paper
• Autoimmunity and dysmetabolism of human acquired immunodeficiency syndrome

  2015cites this paper
• Disseminated tuberculosis in a patient with AIDS on F-18 FDG PET/CT

  2015cites this paper
• Spinal Tuberculosis Evaluated by Means of 18F-FDG PET/CT: Pilot Study

  2014cites this paper
• HLA-B51 associated HIV-1 viral control

  2013cites this paper
• Whole-body FDG-PET Findings in Relation to Immunovirological Status

  2013cites this paper
• Antiviral activity of interferon-γ involved in impaired immune function in infectious diseases

  2013cites this paper
• FDG-PET imaging in HIV infection and tuberculosis.

  2013cites this paper
• Demonstrations of AIDS-associated malignancies and infections at FDG PET-CT

  2011cites this paper
• PET/CT scanning with a high HIV/AIDS prevalence.

  2011cites this paper
• A Brief History and Overview of Toxoplasma gondii

  2010cites this paper
• Cerebral Toxoplasmosis in a Patient with AIDS on F-18 FDG PET/CT

  2010cites this paper
• Development of Broadly Reactive HIV-1/AIDS Virus-like Particle Vaccines

  2010cites this paper
• Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis

  2010cites this paper
• Minimally Invasive Surgery for Children with HIV/AIDS

  2009cites this paper
• Positron emission tomography in patients suffering from HIV-1 infection

  2009cites this paper
• Interferon-γ-mediated pathways and in vitro PBMC proliferation in HIV-infected patients

  2009cites this paper
• MARveling at parasite invasion.

  2008cites this paper
• FUNCTIONS OF THE UNIQUE N-TERMINUS OF A GCN5 HISTONE ACETYLASE IN TOXOPLASMA GONDII

  2007cites this paper
• [Neurological complications of the human immunodeficiency virus (HIV) infection].

  2007cites this paper
• Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.

  2007cites this paper
• Indoleamine-2, 3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection.

  2007cites this paper
• Immune deficiencies and parasitic diseases

  2006cites this paper
• Reduced Peripheral and Mucosal Tropheryma whipplei-Specific Th1 Response in Patients with Whipple’s Disease1

  2006cites this paper
• Emergence of Amphotericin B-Resistant Cryptococcus laurentii Meningoencephalitis Shortly After Treatment for Cryptococcus neoformans Meningitis in a Patient with AIDS

  2006cites this paper
• Antimycobacterial Agents Differ with Respect to Their Bacteriostatic versus Bactericidal Activities in Relation to Time of Exposure, Mycobacterial Growth Phase, and Their Use in Combination

  2005cites this paper
• Construction, Characterization and Immunogenicity of Human Immunodeficiency Virus-Like Particles

  2005cites this paper
• A Case of Vocal Cord Cyst with Cryptococcal Infection

  2005cites this paper
• Combined Effect of Atovaquone and Pyrrolidine Dithiocarbamate in the Treatment of Acute Murine Toxoplasmosis

  2004cites this paper
• Migration and maturation of human dendritic cells infected with Toxoplasma gondii depend on parasite strain type.

  2004cites this paper
• DB-289 Immtech International.

  2003cites this paper